Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)

Summary

This is a multicenter, 2-arm open-label, randomized comparative phase II study in each of two separate cohorts (non-squamous NSCLC and squamous NSCLC) according to histology.

Timeline

Start

2018-11-01

Primary completion

2021-11

Completion

2022-11

Outcome

Outcome not reported

Stopped: “Interest withdrawn”

Drugs

Indications